[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Pages 95705-95710]
[FR Doc No: 2016-31308]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-79648; File No. SR-FINRA-2016-047]

Self-Regulatory Organizations; Financial Industry Regulatory
Authority, Inc.; Notice of Filing of a Proposed Rule Change To Amend
FINRA Rules To Conform to the Commission's Proposed Amendment to
Commission Rule 15c6-1(a) and the Industry-Led Initiative To Shorten
the Standard Settlement Cycle for Most Broker-Dealer Transactions From
T+3 to T+2

December 21, 2016.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on December 14, 2016, Financial Industry Regulatory Authority, Inc.
(``FINRA'') filed with the Securities and Exchange Commission (``SEC''
or ``Commission'') the proposed rule change as described in Items I,
II, and III below, which Items have been prepared by FINRA. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    FINRA is proposing to amend FINRA Rules 2341 (Investment Company
Securities), 11140 (Transactions in Securities ``Ex-Dividend,'' ``Ex-
Rights'' or ``Ex-Warrants''), 11150 (Transactions ``Ex-Interest'' in
Bonds Which Are Dealt in ``Flat''), 11210 (Sent by Each Party), 11320
(Dates of Delivery), 11620 (Computation of Interest), 11810 (Buy-In
Procedures and Requirements), and 11860 (COD Orders) to conform to the
Commission's proposed amendment to SEA Rule 15c6-1(a) to shorten the
standard settlement cycle for most broker-dealer transactions from
three business days after the trade date (``T+3'') to two business days
after the trade date (``T+2'') and the industry-led initiative to
shorten the settlement cycle from T+3 to T+2.\3\
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 78962 (September 28,
2016), 81 FR 69240 (October 5, 2016) (Amendment to Securities
Transaction Settlement Cycle) (File No. S7-22-16) (``SEC Proposing
Release'').
---------------------------------------------------------------------------

    The text of the proposed rule change is available on FINRA's Web
site at http://www.finra.org, at the principal office of FINRA and at
the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, FINRA included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. FINRA has prepared summaries, set forth in sections A,
B, and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
SEC Proposing Release
    On September 28, 2016, the Commission proposed amending SEA Rule
15c6-1(a) to shorten the standard settlement cycle for most broker-
dealer transactions from T+3 to T+2 on the basis that the shorter
settlement cycle would reduce the risks that arise from the value and
number of unsettled securities transactions prior to the completion of
settlement, including credit, market, and liquidity risk directly faced
by U.S. market participants. The proposed rule amendment was published
for comment in the Federal Register on October 5, 2016.\4\
---------------------------------------------------------------------------

    \4\ See supra note 3.
---------------------------------------------------------------------------

Background
    In 1995, the standard U.S. trade settlement cycle for equities,
municipal and corporate bonds, and unit investment trusts, and
financial instruments composed of these products was shortened from
five business days after the trade date (``T+5'') to T+3.\5\
Accordingly, FINRA and other self-regulatory organizations (``SROs'')
amended their respective rules to conform to the T+3 settlement
cycle.\6\ Since that time, the SEC and the financial services industry
have continued to explore the idea of shortening the settlement cycle
even further.\7\
---------------------------------------------------------------------------

    \5\ In 1993, the Commission adopted SEA Rule 15c6-1 which became
effective in 1995. See Securities Exchange Act Release Nos. 33023
(October 6, 1993), 58 FR 52891 (October 13, 1993) and 34952
(November 9, 1994), 59 FR 59137 (November 16, 1994). SEA Rule 15c6-
1(a) provides, in relevant part, that ``a broker or dealer shall not
effect or enter into a contract for the purchase or sale of a
security (other than an exempted security, government security,
municipal security, commercial paper, bankers' acceptances, or
commercial bills) that provides for payment of funds and delivery of
securities later than the third business day after the date of the
contract unless otherwise expressly agreed to by the parties at the
time of the transaction.'' 17 CFR 240.15c6-1(a). Although not
covered by SEA Rule 15c6-1, in 1995, the Commission approved the
Municipal Securities Rulemaking Board's rule change requiring
transactions in municipal securities to settle by T+3. See
Securities Exchange Act Release No. 35427 (February 28, 1995), 60 FR
12798 (March 8, 1995) (Order Approving File No. SR-MSRB-94-10).
    \6\ See, e.g., Securities Exchange Act Release No. 35507 (March
17, 1995), 60 FR 15616 (March 24, 1995) (Order Approving File No.
SR-NASD-94-56); Securities Exchange Act Release No. 35506 (March 17,
1995), 60 FR 15618 (March 24, 1995) (Order Approving File No. SR-
NYSE-94-40); and Securities Exchange Act Release No. 35553 (March
31, 1995), 60 FR 18161 (April 10, 1995) (Order Approving File No.
SR-Amex-94-57).
    \7\ See, e.g., Securities Industry Association (``SIA''), ``SIA
T+1 Business Case Final Report'' (July 2000); Concept Release:
Securities Transactions Settlement, Securities Exchange Act Release
No. 49405 (March 11, 2004), 69 FR 12922 (March 18, 2004); and
Depository Trust & Clearing Corporation, ``Proposal to Launch a New
Cost-Benefit Analysis on Shortening the Settlement Cycle'' (December
2011).
---------------------------------------------------------------------------

    In April 2014, the Depository Trust & Clearing Corporation
(``DTCC'') published its formal recommendation to shorten the standard
U.S. trade settlement cycle to T+2 and announced that it would partner
with market participants and industry organizations to devise the
necessary approach and timelines to achieve T+2.\8\
---------------------------------------------------------------------------

    \8\ See DTCC, ``DTCC Recommends Shortening the U.S. Trade
Settlement Cycle'' (April 2014).
---------------------------------------------------------------------------

    In an effort to improve the overall efficiency of the U.S.
settlement system by reducing the attendant risks in T+3 settlement of
securities transactions, and to align U.S. markets with other major
global markets that have already moved to T+2, DTCC, in collaboration
with the financial services industry, formed an Industry Steering
Committee (``ISC'') and an industry working group and sub-working
groups to facilitate the move to T+2.\9\ In June 2015, the ISC
published a White Paper outlining the activities and proposed time
frames that would be required to move to T+2 in the U.S.\10\
Concurrently, the Securities Industry and Financial Markets Association
(``SIFMA'') and the Investment Company Institute (``ICI'') jointly
submitted a letter to SEC Chair White, expressing support of the
financial services industry's efforts to shorten the settlement cycle
and identifying SEA Rule 15c6-1(a) and several SRO rules that they
believed would require amendments for an

effective transition to T+2.\11\ In March 2016, the ISC announced the
industry target date of September 5, 2017 for the transition to a T+2
settlement cycle to occur.\12\
---------------------------------------------------------------------------

    \9\ The ISC includes, among other participants, DTCC, the
Securities Industry and Financial Markets Association and the
Investment Company Institute.
    \10\ See ``Shortening the Settlement Cycle: The Move to T+2''
(June 18, 2015).
    \11\ See Letter from ICI and SIFMA to Mary Jo White, Chair, SEC,
dated June 18, 2015. See also Letter from Mary Jo White, Chair, SEC,
to Kenneth E. Bentsen, Jr., President and CEO, SIFMA, and Paul
Schott Stevens, President and CEO, ICI, dated September 16, 2015
(expressing her strong support for industry efforts to shorten the
trade settlement cycle to T+2 and commitment to developing a
proposal to amend SEA Rule 15c6-1(a) to require standard settlement
no later than T+2).
    \12\ See ISC Media Alert: ``US T+2 ISC Recommends Move to
Shorter Settlement Cycle On September 5, 2017'' (March 7, 2016).
---------------------------------------------------------------------------

Proposed Rule Change
    In light of the SEC Proposing Release that would amend SEA Rule
15c6-1(a) to require standard settlement no later than T+2 and similar
proposals from other SROs,\13\ FINRA is proposing changes to its rules
pertaining to securities settlement by, among other things, amending
the definition of ``regular way'' settlement as occurring on T+2. SEA
Rule 15c6-1(a) currently establishes standard settlement as occurring
no later than T+3 for all securities, other than an exempted security,
government security, municipal security, commercial paper, bankers'
acceptances, or commercial bills.\14\ FINRA is proposing changes to
rules pertaining to securities settlement to support the industry-led
initiative to shorten the standard settlement cycle to two business
days. Most of the rules that FINRA has identified for these changes are
successors to provisions under the legacy NASD Rules of Fair Practice
and NASD Uniform Practice Code (``UPC'') that were amended when the
Commission adopted SEA Rule 15c6-1(a), which established T+3 as the
standard settlement cycle.\15\ As such, FINRA is proposing to amend
FINRA Rules 2341 (Investment Company Securities), 11140 (Transactions
in Securities ``Ex-Dividend,'' ``Ex-Rights'' or ``Ex-Warrants''), 11150
(Transactions ``Ex-Interest'' in Bonds Which Are Dealt in ``Flat''),
11320 (Dates of Delivery), 11620 (Computation of Interest), and 11860
(COD Orders). In addition, FINRA is proposing to amend FINRA Rules
11210 (Sent by Each Party) and 11810 (Buy-In Procedures and
Requirements) to conform provisions, where appropriate, to the T+2
settlement cycle.\16\
---------------------------------------------------------------------------

    \13\ See, e.g., Securities Exchange Act Release No. 77744 (April
29, 2016), 81 FR 26851 (May 4, 2016) (Order Approving File No. SR-
MSRB-2016-04).
    \14\ See supra note 5.
    \15\ The legacy NASD rules that were changed to conform to the
move from T+5 to T+3 included Section 26 (Investment Companies) of
the Rules of Fair Practice, and Section 5 (Transactions in
Securities ``Ex-Dividend,'' ``Ex-Rights'' or ``Ex-Warrants''),
Section 6 (Transactions ``Ex-Interest'' in Bonds Which Are Dealt in
``Flat''), Section 12 (Dates of Delivery), Section 46 (Computation
of Interest) and Section 64 (Acceptance and Settlement of COD
Orders) of the UPC. See Securities Exchange Act Release No. 35507
(March 17, 1995), 60 FR 15616 (March 24, 1995) (Order Approving File
No. SR-NASD-94-56). See also Notice to Members 95-36 (May 1995)
(enumerating the various sections under the NASD Rules of Fair
Practice and UPC that were amended to implement T+3 settlement for
securities transactions).
    \16\ FINRA Rules 11210 and 11810 are successors to legacy NASD
UPC Sections 9 (Sent by Each Party) and 59 (``Buying-in''),
respectively, which remained unchanged during the transition from
T+5 to T+3. See supra note 15.
---------------------------------------------------------------------------

    The details of the proposed rule change are described below.
(A) FINRA Rule 2341 (Investment Company Securities) \17\
---------------------------------------------------------------------------

    \17\ In June 2016, legacy NASD Rule 2830 (Investment Company
Securities) was adopted as FINRA Rule 2341 in the consolidated FINRA
rulebook without any substantive changes. See Securities Exchange
Act Release No. 78130 (June 22, 2016), 81 FR 42016 (June 28, 2016)
(Notice of Filing and Immediate Effectiveness of File No. SR-FINRA-
2016-019).
---------------------------------------------------------------------------

    Rule 2341(m) requires members, including underwriters, that engage
in direct retail transactions for investment company shares to transmit
payments received from customers for the purchase of investment company
shares to the payee by the end of the third business day after receipt
of a customer's order to purchase the shares, or by the end of one
business day after receipt of a customer's payment for the shares,
whichever is later. FINRA is proposing to amend Rule 2341(m) to change
the three-business day transmittal requirement to two business days,
while retaining the one-business day alternative.
(B) FINRA Rule 11140 (Transactions in Securities ``Ex-Dividend,'' ``Ex-
Rights'' or ``Ex-Warrants'')
    Rule 11140(b)(1) provides that for dividends or distributions, and
the issuance or distribution of warrants, that are less than 25 percent
of the value of the subject security, if definitive information is
received sufficiently in advance of the record date, the date
designated as the ``ex-dividend date'' shall be the second business day
preceding the record date if the record date falls on a business day,
or the third business day preceding the record date if the record date
falls on a day designated by FINRA's UPC Committee as a non-delivery
date. FINRA is proposing to shorten the time frames in Rule 11140(b)(1)
by one business day.
(C) FINRA Rule 11150 (``Ex-Interest'' in Bonds Which Are Dealt in
``Flat'')
    Rule 11150(a) prescribes the manner for establishing ``ex-interest
dates'' for transactions in bonds or other similar evidences of
indebtedness which are traded ``flat.'' Such transactions are ``ex-
interest'' on the second business day preceding the record date if the
record date falls on a business day, on the third business day
preceding the record date if the record date falls on a day other than
a business day, or on the third business day preceding the date on
which an interest payment is to be made if no record date has been
fixed. FINRA is proposing to shorten the time frames in Rule 11150(a)
by one business day.
(D) FINRA Rule 11210 (Sent by Each Party)
    Paragraphs (c) and (d) of Rule 11210 set forth the ``Don't Know''
(``DK'') voluntary procedures for using ``DK Notices'' (FINRA Form No.
101) or other forms of notices, respectively. Depending upon the notice
used, a confirming member may follow the ``DK'' procedures when it
sends a comparison or confirmation of a trade (other than one that
clears through the National Securities Clearing Corporation (``NSCC'')
or other registered clearing agency), but does not receive a comparison
or confirmation or a signed ``DK'' from the contra-member by the close
of four business days following the trade date of the transaction
(``T+4''). The procedures generally provide that after T+4, the
confirming member shall send a ``DK Notice'' (or similar notice) to the
contra-member. The contra-member then has four business days after
receipt of the confirming member's notice to either confirm or ``DK''
the transaction.
    FINRA is proposing to amend paragraphs (c) and (d) of Rule 11210 to
provide that the ``DK'' procedures may be used by the confirming member
if it does not receive a comparison or confirmation or signed ``DK''
from the contra-member by the close of one business day following the
trade date of the transaction, rather than the current T+4.\18\ In
addition, FINRA is proposing amendments to paragraphs (c)(2)(A),
(c)(3), and (d)(5) of Rule 11210 to adjust

the time in which a contra-member has to respond to a ``DK Notice'' (or
similar notice) from four business days after the contra-member's
receipt of the notice to two business days. The proposed rule change
would also make non-substantive technical changes to paragraph
(c)(2)(A) to reflect FINRA Manual style convention.
---------------------------------------------------------------------------

    \18\ As stated above, the time frames in Rule 11210 remained
unchanged during the transition from T+5 to T+3. In light of the
industry-led initiative to shorten the standard settlement cycle and
the SEC Proposing Release to amend SEA Rule 15c6-1(a) to establish
T+2 as the standard settlement for most broker-dealer transactions,
FINRA believes that the current time frames in Rule 11210 are more
protracted than necessary even in a T+3 environment and as such,
FINRA is proposing to amend these time frames to reflect more
current industry practices.
---------------------------------------------------------------------------

(E) FINRA Rule 11320 (Dates of Delivery)
    Rule 11320 prescribes delivery dates for various transactions.
Paragraph (b) states that for a ``regular way'' transaction, delivery
must be made on, but not before, the third business day after the date
of the transaction. FINRA is proposing to amend Rule 11320(b) to change
the reference to third business day to second business day. Paragraph
(c) provides that in a ``seller's option'' transaction, delivery may be
made by the seller on any business day after the third business day
following the date of the transaction. FINRA is proposing to amend Rule
11320(c) to change the reference to third business day to second
business day.
(F) FINRA Rule 11620 (Computation of Interest)
    In the settlement of contracts in interest-paying securities other
than for cash, Rule 11620(a) requires the calculation of interest at
the rate specified in the security up to, but not including, the third
business day after the date of the transaction. The proposed amendment
would shorten the time frame to the second business day. In addition,
the proposed amendment would make non-substantive technical changes to
the title of paragraph (a).
(G) FINRA Rule 11810 (Buy-in Procedures and Requirements)
    Rule 11810(j)(1)(A) sets forth the fail-to-deliver and liability
notice procedures where a securities contract is for warrants, rights,
convertible securities or other securities which have been called for
redemption; are due to expire by their terms; are the subject of a
tender or exchange offer; or are subject to other expiring events such
as a record date for the underlying security and the last day on which
the securities must be delivered or surrendered is the settlement date
of the contract or later.\19\
---------------------------------------------------------------------------

    \19\ Rule 11810(j) is the successor to legacy NASD UPC Section
59(i) (Failure to Deliver and Liability Notice Procedures). When
this provision was added to NASD's existing close-out procedures in
1984, it was drafted to be similar to the liability notice
provisions adopted by the NSCC so that members that were also
participants in NSCC could use the same procedures for both ex-
clearing and NSCC cleared transactions, thereby simplifying members'
back office procedures. See Securities Exchange Act Release No.
21262 (August 22, 1984), 49 FR 34321 (August 29, 1984) (Notice of
Filing of File No. SR-NASD-84-20). See also Securities Exchange Act
Release No. 21406 (October 19, 1984), 49 FR 43006 (October 25, 1984)
(Order Approving File No. SR-NASD-84-20).
---------------------------------------------------------------------------

    Under Rule 11810(j)(1)(A), the receiving member delivers a
liability notice to the owing counterparty. The liability notice sets a
cutoff date for the delivery of the securities by the counterparty and
provides notice to the counterparty of the liability attendant to its
failure to deliver the securities in time. If the owing counterparty,
or delivering member, delivers the securities in response to the
liability notice, it has met its delivery obligation. If the delivering
member fails to deliver the securities on the expiration date, it will
be liable for any damages that may accrue thereby.
    Rule 11810(j)(1)(A) further provides that when both parties to a
contract are participants in a registered clearing agency that has an
automated liability notification service, transmission of the liability
notice must be accomplished through such system.\20\ When the parties
to a contract are not both participants in a registered clearing agency
that has an automated liability notification service, such notice must
be issued using written or comparable electronic media having immediate
receipt capabilities not later than one business day prior to the
latest time and the date of the offer or other event in order to obtain
the protection provided by the Rule.\21\
---------------------------------------------------------------------------

    \20\ In 2007, NYSE Rule 180 was amended to require that when the
parties to a failed contract were both participants in a registered
clearing agency that had an automated service for notifying a
failing party of the liability that will be attendant to a failure
to deliver and the contract was to be settled through the facilities
of that registered clearing agency, the transmission of the
liability notification must be accomplished through the use of the
registered clearing agency's automated liability notification
system. See Securities Exchange Act Release No. 55132 (January 19,
2007), 72 FR 3896 (January 26, 2007) (Order Approving File No. SR-
NYSE-2006-57). FINRA followed suit and effective in 2008, Rule
11810(j) mandated the use of an automated liability notification
system when the parties to a contract are participants in a
registered clearing agency that has an automated service for
notifying a failing party of the liability that would be attendant
to failure to deliver. See Securities Exchange Act Release No. 56972
(December 14, 2007), 72 FR 73927 (December 28, 2007) (Order
Approving File No. SR-NASD-2007-035). See also Regulatory Notice 08-
06 (February 2008).
    \21\ While Rule 11810 has undergone amendments over the years,
the one-day time frame in paragraph (j) has remained unchanged. The
one-day time frame also appears in comparable provisions of other
SROs. See, e.g., NSCC Rules & Procedures, Procedure X (Execution of
Buy-Ins) (Effective August 10, 2016); NYSE Rule 282.65 (Fail to
Deliver and Liability Notice Procedures); and Nasdaq Rule IM-11810
(Buying-in). See also infra note 30 and accompanying text.
---------------------------------------------------------------------------

    Given the proposed shortened settlement cycle, FINRA is proposing
to amend Rule 11810(j)(1)(A) in situations where both parties to a
contract are not participants of a registered clearing agency with an
automated notification service, by extending the time frame for
delivery of the liability notice. Rule 11810(j)(1)(A) would be amended
to provide that in such cases, the receiving member must send the
liability notice to the delivering member as soon as practicable but
not later than two hours prior to the cutoff time set forth in the
instructions on a specific offer or other event to obtain the
protection provided by the Rule. FINRA believes that extending the time
given to the receiving member to transmit liability notifications will
maintain the efficiency of the notification process while mitigating
the possible overuse of such notifications.
    Currently, FINRA understands that the identity of the counterparty,
or delivering member, becomes known to the receiving member by mid-day
on the business day after trade date (``T+1''), and by that time, the
receiving member will generally also know which transactions are
subject to an event identified in Rule 11810(j)(1)(A) that would prompt
the receiving member to issue a liability notice to the delivering
member. FINRA believes that the receiving member regularly issues
liability notices to the seller or other parties from which the
securities involved are due when the security is subject to an event
identified in Rule 11810(j)(1)(A) during the settlement cycle as a way
to mitigate the risk of a potential fail-to-deliver. In the current T+3
settlement environment, the one business day time frame gives the
receiving member the requisite time needed to identify the parties
involved and undertake the liability notification process.
    However, FINRA believes that the move to a T+2 settlement
environment will create inefficiencies in the liability notification
process under Rule 11810(j)(1)(A) when both parties to a contract are
not participants in a registered clearing agency with an automated
notification service. The shorter settlement cycle, with the loss of
one-business day, would not afford the receiving member sufficient time
to: (1) Ascertain that the securities are subject to an event listed in
Rule 11810(j)(1)(A) during the settlement cycle; (2) identify the
delivering member and other parties from which the securities involved
are due; and (3) determine the likelihood that such parties may fail to
deliver. Where the receiving member has sufficient time (e.g., one
business day

after), it can transmit liability notices as needed to the right
parties. However, as a consequence of the shortened settlement cycle,
the receiving member would be compelled to issue liability notices
proactively to all potentially failing parties as a matter of course to
preserve its rights against such parties without the benefit of knowing
which transactions would actually necessitate the delivery of such
notice. This would create a significant increase in the volume of
liability notices members send and receive, many of which may be
unnecessary. Members would then have to manage this overabundance of
liability notices, increasing the possibility of errors, which would
adversely impact the efficiency of the process. Therefore, FINRA
believes its proposal to extend the time for the receiving member to
deliver a liability notice when the parties to a contract are not both
participants in a registered clearing agency with an automated
notification service would help alleviate the potential burden on the
liability notification process in a T+2 settlement environment.
(H) FINRA Rule 11860 (COD Orders)
    Rule 11860(a) directs members to follow various procedures before
accepting collect on delivery (``COD'') or payment on delivery
(``POD'') orders. Rule 11860(a)(4)(A) states that the member must
obtain an agreement from the customer that the customer will furnish
instructions to the agent no later than the close of business on the
second business day after the date of execution of the trade to which
the confirmation relates in the case of a purchase by the customer
where the agent is to receive the securities against payment, or COD.
In light of the proposed shortened settlement cycle, FINRA is proposing
to amend Rule 11860(a)(4)(A) to provide that the time period for a
customer buying COD to furnish instructions to the agent will be no
later than the close of business on the first business day after the
date of execution of the trade, rather than the close of business on
the second business day.
    If the Commission approves the proposed rule change, FINRA will
announce the effective date of the proposed rule change in a Regulatory
Notice, which date would correspond with the industry-led transition to
a T+2 standard settlement, and the effective date of the Commission's
proposed amendment to SEA Rule 15c6-1(a) to require standard settlement
no later than T+2.

2. Statutory Basis

    FINRA believes that the proposed rule change is consistent with the
provisions of Section 15A(b)(6) of the Act,\22\ which requires, among
other things, that FINRA rules must be designed to prevent fraudulent
and manipulative acts and practices, to promote just and equitable
principles of trade, to foster cooperation and coordination with
persons engaged in regulating, clearing, settling, processing
information with respect to, and facilitating transactions in
securities, and, in general, to protect investors and the public
interest. FINRA believes that the proposed rule change supports the
industry-led initiative to shorten the settlement cycle to two business
days. Moreover, the proposed rule change is consistent with the SEC's
proposed amendment to SEA Rule 15c6-1(a) to require standard settlement
no later than T+2. FINRA believes that the proposed rule change will
provide the regulatory certainty to facilitate the industry-led move to
a T+2 settlement cycle.
---------------------------------------------------------------------------

    \22\ 15 U.S.C. 78o-3(b)(6).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    FINRA does not believe that the proposed rule change will result in
any burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act. The proposed rule change makes
changes to rules pertaining to securities settlement and is intended to
facilitate the implementation of the industry-led transition to a T+2
settlement cycle. Moreover, the proposed rule changes are consistent
with the SEC's proposed amendment to SEA Rule 15c6-1(a) to require
standard settlement no later than T+2. Accordingly, FINRA believes that
the proposed changes do not impose any burdens on the industry in
addition to those necessary to implement amendments to SEA Rule 15c6-
1(a) as described and enumerated in the SEC Proposing Release.\23\
---------------------------------------------------------------------------

    \23\ See supra note 3.
---------------------------------------------------------------------------

    These conforming changes include changes to rules that specifically
establish the settlement cycle as well as rules that establish time
frames based on settlement dates, including for certain post-settlement
rights and obligations. FINRA believes that the proposed changes set
forth in the filing are necessary to support a standard settlement
cycle across the U.S. for secondary market transactions in equities,
corporate and municipal bonds, unit investment trusts, and financial
instruments composed of these products, among others.\24\ A standard
U.S. settlement cycle for such products is critical for the operation
of fair and orderly markets.
---------------------------------------------------------------------------

    \24\ See supra note 3.
---------------------------------------------------------------------------

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The proposed rule change was published for comment in Regulatory
Notice 16-09 (March 2016). Eight comments were received in response to
the Regulatory Notice.\25\ A copy of the Regulatory Notice is attached
as Exhibit 2a.\26\ A list of commenters is attached as Exhibit 2b and
copies of the comment letters received in response to the Regulatory
Notice are attached as Exhibit 2c.
---------------------------------------------------------------------------

    \25\ See Letter from Michael Nicholas, Chief Executive Officer,
Bond Dealers of America, to Marcia E. Asquith, Corporate Secretary,
FINRA, dated April 4, 2016 (``BDA''); letter from Stephen E. Roth,
Sutherland Asbill & Brennan LLP on behalf of the Committee of
Annuity Insurers, to Marcia E. Asquith, Corporate Secretary, FINRA,
dated April 4, 2016 (``CAI''); letter from Norman L. Ashkenas, Chief
Compliance Officer, Fidelity Brokerage Services, LLC, and Richard J.
O'Brien, Chief Compliance Officer, National Financial Services, LLC,
to Marcia E. Asquith, Corporate Secretary, FINRA, dated April 4,
2016 (``Fidelity''); letter from David T. Bellaire, Executive Vice
President and General Counsel, Financial Services Institute, to
Marcia E. Asquith, Corporate Secretary, FINRA, dated April 4, 2016
(``FSI''); letter from Martin A. Burns, Chief Industry Operations
Officer, Investment Company Institute, to Marcia E. Asquith,
Corporate Secretary, FINRA, dated April 4, 2016 (``ICI''); letter
from Thomas F. Price, Managing Director, Operations, Technology &
BCP, Securities Industry and Financial Markets Association, to
Marcia E. Asquith, Corporate Secretary, FINRA, dated April 4, 2016
(``SIFMA'') (April 4, 2016); letter from Manisha Kimmel, Chief
Regulatory Officer, Wealth Management, Thomson Reuters, to Marcia E.
Asquith, Corporate Secretary, FINRA, dated April 4, 2016 (``Thomson
Reuters''); and letter from Robert J. McCarthy, Director of
Regulatory Policy, Wells Fargo Advisors, LLC, to Marcia E. Asquith,
Corporate Secretary, FINRA, dated April 4, 2016 (``WFA'').
    \26\ The Commission notes that the exhibits referred to are
attached to the filing and not to this Notice.
---------------------------------------------------------------------------

    Of the eight comment letters received, seven expressed support for
the industry-led move to T+2 stating, among other benefits, that the
move will align U.S. markets with international markets that already
work in the T+2 environment, improve the overall efficiency and
liquidity of the securities markets, and the stability of the financial
system by reducing counterparty risk and pro-cyclical and liquidity
demands, and decreasing clearing capital requirements.\27\ Several

commenters encouraged FINRA to coordinate with other regulators to make
the necessary regulatory changes to help facilitate the move to a T+2
standard settlement cycle \28\ with two commenters \29\ providing their
views on the proposed amendments to two rules under the FINRA Rule
11800 Series (Close-Out Procedures).
---------------------------------------------------------------------------

    \27\ BDA, Fidelity, FSI, ICI, SIFMA, Thomson Reuters and WFA.
CAI did not comment on the proposed rule amendments and instead
requested FINRA's ``acknowledgment and confirmation that insurance
securities products, which are currently exempt from the T+3
settlement cycle requirements, will continue to be exempt from the
settlement cycle requirements after the timetable is shortened to
T+2.'' The Commission has granted an exemption for transactions
involving certain insurance contracts from the scope of SEA Rule
15c6-1. See Securities Exchange Act Release No. 35815 (June 6,
1995), 60 FR 30906 (June 12, 1995). FINRA notes that any
modification or revocation of the current exemptions to SEA Rule
15c6-1 rests with the Commission.
    \28\ Fidelity, FSI, ICI, and Thomson Reuters.
    \29\ BDA and SIFMA.
---------------------------------------------------------------------------

FINRA Rule 11810(j)--Failure To Deliver and Liability Notice Procedures
    In its comment letter, SIFMA raised a concern with the one-day time
frame in Rule 11810(j)(1)(A), asserting that the requirement for the
delivering member to deliver a liability notice to the receiving member
no later than one business day prior to the latest time and the date of
the offer or other event in order to obtain the protection provided by
the Rule may no longer be appropriate in a T+2 environment in some
situations such as where the delivery obligation is transferred to
another party as a result of continuous net settlement, settlements
outside of the NSCC, and settlements involving a third party that is
not a FINRA member firm. SIFMA noted that NYSE Rule 180 (Failure to
Deliver) includes a similar requirement for NYSE member firms that are
participants in a registered clearing agency to transmit liability
notification through an automated notification service and proposed
amending Rule 11810(j)(1)(A) to omit the reference to a notification
time frame, which would align with NYSE Rule 180.\30\ In the
alternative, SIFMA proposed amending Rule 11810(j)(1)(A) to require
that the liability notice be delivered in a ``reasonable amount of
time'' ahead of the settlement obligation in light of facts and
circumstances. SIFMA maintained that under either proposed amendment to
paragraph (j), the delivering member would be liable for any damages
caused by its failure to deliver in a timely fashion.
---------------------------------------------------------------------------

    \30\ See NYSE Rule 180 (Failure to Deliver) providing in part
that ``[w]hen the parties to a contract are both participants in a
registered clearing agency which has an automated service for
notifying a failing party of the liability that will be attendant to
a failure to deliver and that contract was to be settled through the
facilities of said registered clearing agency, the transmission of
the liability notification must be accomplished through use of said
automated notification service.'' FINRA notes that NYSE Rule 180
does not address the transmission of the liability notification for
parties to a contract that are not both participants in a registered
clearing agency (or non-participants). The transmission of the
liability notification for non-participants is addressed under NYSE
Rule 282.65 (Failure to Deliver and Liability Notice Procedures).
See supra note 21.
---------------------------------------------------------------------------

    While FINRA did not initially propose amendments to Rule 11810 for
the T+2 initiative,\31\ in light of SIFMA's concern regarding Rule
11810(j)(1)(A), FINRA is proposing to amend the Rule to provide that,
where both parties to a contract are not participants of a registered
clearing agency with an automated notification service, the receiving
member must send the liability notice to the delivering member as soon
as practicable but not later than two hours prior to the cutoff time
set forth in the instructions on a specific offer or other event to
obtain the protection provided by the Rule.\32\
---------------------------------------------------------------------------

    \31\ See Regulatory Notice 16-09 (March 2016).
    \32\ FINRA expects similar amendments to other comparable SRO
provisions in NYSE Rule 282.65 (Fail to Deliver and Liability Notice
Procedures) and Nasdaq Rule IM-11810 (Buying-in), and NSCC Rules &
Procedures, Procedure X (Execution of Buy-Ins) to address SIFMA's
concern about the one-day notification time frame.
---------------------------------------------------------------------------

FINRA Rule 11860 (COD Orders)
    Rule 11860(a)(3) requires a member that accepts a COD or POD order
from a customer to deliver to the customer a confirmation not later
than the close of business on T+1. In Regulatory Notice 16-09, FINRA
proposed shortening the confirmation delivery time frame to the close
of business on the date of the trade (``T+0''). In its comment letter,
BDA urged FINRA to consider leaving the requirement for delivering
customer confirmations under Rule 11860(a)(3) unchanged and allow
customer confirmations to continue to be sent T+1 to minimize the
regulatory and compliance costs of the proposed amendment without
limiting the risk-reducing benefits of the shortened settlement cycle.
BDA asserted that shortening confirmation delivery to T+0 would be a
tremendous undertaking for small firms that would need to commit large
amounts of internal resources to change the systems and processes that
are used to deliver confirmations in order to process confirmations on
a T+0 basis.
    FINRA has considered the comment and agrees that the proposed
change to T+0 may present significant difficulties for member firms,
particularly small firms. Moreover, FINRA believes that the existing
requirement to deliver customer confirmations on T+1 would still assure
the efficient clearance and settlement of transactions in a T+2
settlement environment. Therefore, in order to remain aligned with the
provisions of other SROs and current industry practices, FINRA has
determined to retain the current T+1 confirmation delivery requirement
under Rule 11860(a)(3).\33\
---------------------------------------------------------------------------

    \33\ In Regulatory Notice 16-09, FINRA preliminarily identified
Rule 11210(a) (Comparisons or Confirmations) to undergo an amendment
to reflect the T+2 settlement cycle. Rule 11210(a)(1) requires each
party to a transaction, other than a cash transaction, to send a
Uniform Comparison or Confirmation on or before T+1. FINRA proposed
changing the delivery time frame to T+0. While not specifically
referenced by BDA, Rule 11210(a) would raise similar concerns. Thus,
the time frame under Rule 11210(a)(1) for sending a Uniform
Comparison or Confirmation would also remain unchanged at T+1.
---------------------------------------------------------------------------

Other Comments
    Several commenters conveyed the importance of testing systems and
educating market participants and retail investors on the impacts of a
shorter settlement cycle.\34\ BDA explained that currently, a customer
has five business days to submit payment for purchases of securities in
a cash account or in a margin account before a broker-dealer would
cancel or liquidate the transaction in whole or in part.\35\ BDA
further explained that ``[s]hortening the settlement cycle to T+2 would
automatically reduce the timeframe before a dealer would have to
liquidate an unpaid for transaction to T+4.'' BDA noted that shortening
the settlement cycle by one day may negatively impact retail clients
that still use checks, which may not be sent, received, processed, and
cleared, within the shortened four-day window. BDA expressed that firms
that do a large amount of retail business would need ample time to
communicate the practical impacts on a shortened settlement cycle.
---------------------------------------------------------------------------

    \34\ BDA, FSI and WFA.
    \35\ Federal Reserve Board Regulation T governs, among other
things, the extension of credit by broker-dealers to customers to
pay for the purchase of securities. Regulation T provides that a
customer has one payment period (currently five business days) to
submit payment for purchases of securities in a cash account or in a
margin account. 12 CFR 220.2 (Definitions), 220.4 (Margin Account)
and 220.8 (Cash Account).
---------------------------------------------------------------------------

    FINRA recognizes that market participants will have to undergo
systemic and procedural changes to implement the shorter payment period
for a securities purchase as part of the ongoing transition to the T+2
framework. As BDA acknowledged, the 2017 timeline should allow firms to
make all the necessary changes to systems that the proposed rule will
require. FINRA further recognizes the importance of educating retail
investors regarding the impact of a shortened settlement cycle and is
committed to

working with market participants to provide the information necessary
to educate retail investors.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) by order approve or disapprove such proposed rule change, or
    (B) institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-FINRA-2016-047 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-FINRA-2016-047. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of such filing also will be available
for inspection and copying at the principal office of FINRA. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-FINRA-2016-047 and should be
submitted on or before January 18, 2017.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\36\
---------------------------------------------------------------------------

    \36\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2016-31308 Filed 12-27-16; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 83, Number 176 (Tuesday, September 11, 2018)]
[Rules and Regulations]
[Pages 45816-45817]
[FR Doc No: 2018-19486]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2018-0810; Airspace Docket No. 18-ASO-16]
RIN 2120-AA66

Amendment of Class D Airspace; Olive Branch, MS

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule, technical amendment.

-----------------------------------------------------------------------

SUMMARY: This action amends Class D airspace for Olive Branch Airport,
Olive Branch, MS, by adding the Memphis Class B exclusionary language
back into the legal description. The exclusionary language was
inadvertently omitted from the final rule published July 30, 2018,
amending Class D and Class E airspace at this airport.

DATES: Effective 0901 UTC, September 11, 2018. The Director of the
Federal Register approves this incorporation by reference action under
title 1, Code of Federal Regulations, part 51, subject to the annual
revision of FAA Order 7400.11 and publication of conforming amendments.

ADDRESSES: FAA Order 7400.11B, Airspace Designations and Reporting
Points, and subsequent amendments can be viewed online at http://www.faa.gov/air_traffic/publications/. For further information, you can
contact the Airspace Policy Group, Federal Aviation

Administration, 800 Independence Avenue SW, Washington, DC 20591;
telephone:<PHONE_NUMBER>. The Order is also available for inspection
at the National Archives and Records Administration (NARA). For
information on the availability of FAA Order 7400.11B at NARA, call
(202) 741-6030, or go to https://www.archives.gov/federal-register/cfr/ibr-locations.html.
    FAA Order 7400.11, Airspace Designations and Reporting Points, is
published yearly and effective on September 15.

FOR FURTHER INFORMATION CONTACT: John Fornito, Operations Support
Group, Eastern Service Center, Federal Aviation Administration, 1701
Columbia Avenue, College Park, GA 30337; telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Authority for This Rulemaking

    The FAA's authority to issue rules regarding aviation safety is
found in Title 49 of the United States Code. Subtitle I, Section 106
describes the authority of the FAA Administrator. Subtitle VII,
Aviation Programs, describes in more detail the scope of the agency's
authority. This rulemaking is promulgated under the authority described
in Subtitle VII, Part A, Subpart I, Section 40103. Under that section,
the FAA is charged with prescribing regulations to assign the use of
airspace necessary to ensure the safety of aircraft and the efficient
use of airspace. This regulation is within the scope of that authority
as it amends Class D airspace at Olive Branch Airport, Olive Branch,
MS, to support IFR operations at the airport.

History

    The FAA published a final rule in the Federal Register (83 FR
36402; July 30, 2018) for Docket No. FAA-2017-0866 amending Class D
airspace, removing Class E airspace, and establishing Class E airspace
at Olive Branch Airport, Olive Branch, MS.
    Subsequent to publication, the FAA discovered the Memphis Class B
airspace exclusionary language was omitted from the Class D legal
description of the airport. This rule adds the Class B exclusionary
language back into the legal description.
    Class D airspace designations are published in paragraph 5000, of
FAA Order 7400.11B dated August 3, 2017, and effective September 15,
2017, which is incorporated by reference in 14 CFR part 71.1. The Class
D and E airspace designations listed in this document will be published
subsequently in the Order.

Availability and Summary of Documents for Incorporation by Reference

    This document amends FAA Order 7400.11B, Airspace Designations and
Reporting Points, dated August 3, 2017, and effective September 15,
2017. FAA Order 7400.11B is publicly available as listed in the
ADDRESSES section of this document. FAA Order 7400.11B lists Class A,
B, C, D, and E airspace areas, air traffic service routes, and
reporting points.

The Rule

    This action amends Title 14 Code of Federal Regulations (14 CFR)
part 71 by adding to the Class D legal description for Olive Branch
Airport, Olive Branch, MS, the following text that reads ``excluding
that airspace within the Memphis Class B airspace area.''
    Accordingly, action is take herein to add this exclusion of Memphis
Class B airspace to the legal description in the interest of flight
safety. Therefore, I find that notice and public procedure under 5
U.S.C. 553(b) are impracticable and contrary to the public interest.
    To avoid confusion on the part of pilots flying in the vicinity of
Olive Branch Airport, Olive Branch, MS, the FAA finds good cause,
pursuant to 5 U.S.C. 553(d), for making this rule effective in less
than 30 days in order to promote the safe and efficient handling of air
traffic in the area.

Regulatory Notices and Analyses

    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
Therefore, this regulation: (1) Is not a ``significant regulatory
action'' under Executive Order 12866; (2) is not a ``significant rule''
under DOT Regulatory Policies and Procedures (44 FR 11034; February 26,
1979); and (3) does not warrant preparation of a regulatory evaluation
as the anticipated impact is so minimal. Since this is a routine matter
that only affects air traffic procedures and air navigation, it is
certified that this rule, when promulgated, does not have a significant
economic impact on a substantial number of small entities under the
criteria of the Regulatory Flexibility Act.

Environmental Review

    The FAA has determined that this action qualifies for categorical
exclusion under the National Environmental Policy Act in accordance
with FAA Order 1050.1F, ``Environmental Impacts: Policies and
Procedures,'' paragraph 5-6.5a. This airspace action is not expected to
cause any potentially significant environmental impacts, and no
extraordinary circumstances exist that warrant preparation of an
environmental assessment.

Lists of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

Adoption of the Amendment

    In consideration of the foregoing, the Federal Aviation
Administration amends 14 CFR part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for part 71 continues to read as follows:

    Authority:  49 U.S.C. 106(f), 106(g); 40103, 40113, 40120; E.O.
10854, 24 FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR 71.1 of Federal Aviation
Administration Order 7400.11B, Airspace Designations and Reporting
Points, dated August 3, 2017, effective September 15, 2017, is amended
as follows:

Paragraph 5000 Class D Airspace.

* * * * *

ASO MS D Olive Branch, MS [Amended]

Olive Branch Airport, MS
    (Lat. 34[deg]58'44'' N, long. 89[deg]47'13'' W)

    That airspace extending upward from the surface to and including
2,900 feet within a 4.1-mile radius of Olive Branch Airport,
excluding that airspace within the Memphis Class B airspace area.
This Class D airspace area is effective during the specific days and
times established in advance by a Notice to Airmen. The effective
days and times will thereafter be continuously published in the
Chart Supplement.

    Issued in College Park, Georgia, on August 28, 2018.
Ryan W. Almasy,
Manager, Operations Support Group, Eastern Service Center, Air Traffic
Organization.
[FR Doc. 2018-19486 Filed 9-10-18; 8:45 am]
 BILLING CODE 4910-13-P


F025	Chloromethane, dichloromethane, trichloromethane, carbon tetrachloride, chloroethylene, l,l-dichloroethane, l,2-dichloroethane, trans-l,2-dichloroethylene, l,l-dichloroethylene, l,l,l-trichloroethane, 1,1,2-trichloroethane, trichloroethylene, l,l,l,2-tetrachloroethane, l,l,2,2-tetrachloroethane, tetrachloroethylene, pentachloroethane, hexachloroethane, allyl chloride (3-chloropropene), dichloropropane, dichloropropene, 2-chloro-l, 3-butadiene, hexachloro-l, 3-butadiene, hexachloro- cyclopentadiene, hexachlorocyclohexane, benzene, chlorobenzene, dichlorobenzenes, 1,2,4-trichlorobenzene, tetrachlorobenzene, pentachlorobenzene, hexachlorobenzene, toluene, naphthalene
F026	Tetra-, penta-, and hexachlorodibenzo-p-dioxins; tetra-, penta-, and hexa- chlorodibenzofurans
F027	Tetra-, penta-, and hexachlorodibenzo-p-dioxins; tetra-, penta-, and hexachlorodibenzofurans; tri-, tetra-, and pentachlorophenols and their chlorophenoxy derivative acids, esters, ethers, amine, and other salts
F028	Tetra-, penta-, and hexachlorodibenzo-p- dioxins; tetra-, penta-, and hexachlorodibenzofurans; tri-, tetra- and pentachloro- phenols and their chlorophenoxy derivative acids, esters, ethers, amine, and other salts
F032	Benz(a)anthracene, benzol(a)pyrene, dibenz(a,h)-anthracene, indeno (1,2,3-cd)pyrene, pentachlorophenol, arsenic, chromium, tetra-, penta-, hexa-, heptachlorodibenzo-p-dioxins, tetra-, pentra-, hexa-, heptachlorodibenzofurans.
F034	Benz(a)anthracene, benzo (k)fluoranthene, benzo(a)pyrene, dibenz(a,h)anthracene, indeno (1,2,3-cd)pyrene, naphthalene, arsenic, chromium.
F035	Arsenic, chromium, lead.
F037	Benzene, benzo(a)pyrene, chrysene, lead, chromium.
F038	Benzene, benzo(a)pyrene, chrysene, lead, chromium.
F039	All constitutents for which treatment standards are specified for multi-source leachate (wastewaters) and nonwastewater) under Section 14A of Chapter 852.
K001	Pentachlorophenol, phenol, 2-chlorophenol, p-chloro- m-cresol, 2,4-dimethyl- phenol, 2,4-dinitrophenol, trichlorophenols, tetra- chlorophenols, 2,4-dinitro- phenol, creosote, chrysene, naphthalene, fluoranthene, benzo(b)fluoranthene, benzo(a)pyrene, indeno (1,2,3-cd)pyrene, benz(a) anthracene, dibenz(a) anthracene, acenaphthalene.
K002	Hexavalent chromium, lead
K003	Hexavalent chromium, lead
K004	Hexavalent chromium
K005	Hexavalent chromium, lead
K006	Hexavalent chromium
K007	Cyanide (complexed), hexavalent chromium
K008	Hexavalent chromium
K009	Chloroform, formaldehyde, methylene chloride, methyl chloride, paraldehyde, formic acid
K010	Chloroform, formaldehyde, methylene chloride, methyl chloride, paraldehyde, formic acid, chloro- acetaldehyde
K011	Acrylonitrile, acetonitrile, hydrocyanic acid
K013	Hydrocyanic acid, acrylonitrile, acetonitrile
K014	Acetonitrile, acrylamide
K015	Benzyl chloride, chlorobenzene, toluene, benzotrichloride
K016	Hexachlorobenzene, hexachlorobutadiene, carbon tetrachloride, hexachloro- ethane, perchloroethylene
K017	Epichlorohydrin, chloro ethers [bis (chloromethyl) ether and bis (2-chloroethyl) ethers], trichloropropane, dichloropropanols
K018	l,2-dichloroethane, tri- chloroethylene, hexachloro- butadiene, hexachlorobenzene
K019	Ethylene dichloride, l,l,l- trichloroethane, l,l,2- trichloroethane, tetra- chloroethanes (l,l,2,2-tetra- chloroethane and l,l,l,2-tetrachloroethane), trichloroethylene, tetra- chloroethylene, carbon tetrachloride, chloroform, vinyl chloride, vinylidene chloride
K020	Ethylene dichloride, l,l,l-trichloroethane, l,l,2-trichloroethane, tetra- chloroethanes (l,l,2,2-tetra- chloroethane and l,l,l,2-tetrachloroethane), trichloroethylene, tetrachloroethylene, carbon tetrachloride, chloroform, vinyl chloride, vinylidene chloride
K021	Antimony, carbon tetrachloride, chloroform
K022	Phenol, tars (polycyclic aromatic hydrocarbons)
K023	Phthalic anhydride, maleic anhydride
K024	Phthalic anhydride, l,4-naphthoquinone
K025	Meta-dinitrobenzene, 2,4-dinitrotoluene
K026	Paraldehyde, pyridines, 2-picoline
K027	Toluene diisocyanate, toluene-2,4-diamine
K028	l,l,l-trichloroethane, vinyl chlorideK029	l,2-dichloroethane, l,l,l-trichloroethane, vinyl chloride, vinylidene chloride, chloroform
K030	Hexachlorobenzene, hexachlorobutadiene, hexachloroethane, l,l,l,2- tetrachloroethane, l,l,2,2-tetrachloroethane, ethylene dichloride
K031	Arsenic
K032	Hexachlorocyclopentadiene
K033	Hexachlorocyclopentadiene
K034	Hexachlorocyclopentadiene
K035	Creosote, chrysene, naphthalene, fluoranthene benzo(b)fluoranthene, benzo(a)pyrene, indeno (l,2,3-cd) pyrene, benzo (a)anthracene, dibenzo(a) anthracene, acenaphthalene
K036	Toluene, phosphorodithioic and phosphorothioic acid esters
K037	Toluene, phosphorodithioic and phosphorothioic acid esters
K038	Phorate, formaldehyde, phosphorodithioic and phosphorothioic acid esters
K039	Phosphorodithioic and phosphorothioic acid esters
K040	Phorate, formaldehyde, phosphorodithioic and phosphorothioic acid esters
K041	Toxaphene
K042	Hexachlorobenzene, ortho- dichlorobenzene
K043	2,4-dichlorophenol, 2,6-dichlorophenol, 2,4,6-trichlorophenol
K044	N.A.
K045	N.A.
K046	Lead
K047	N.A.
K048	Hexavalent chromium, lead
K049	Hexavalent chromium, lead
K050	Hexavalent chromium
K051	Hexavalent chromium, lead
K052	Lead
K060	Cyanide, napthalene, phenolic compounds, arsenic
K061	Hexavalent chromium, lead, cadmium
K062	Hexavalent chromium, lead
K064	Lead, Cadmium
K065	Lead, Cadmium
K066	Lead, Cadmium
K068	Cyanide (Complexes)
K069	Hexavalent chromium, lead, cadmium
K071	Mercury
K073	Chloroform, carbon tetra- chloride, hexachloroethane, trichloroethane, tetra- chloroethylene, dichloro- ethylene, 1,1,2,2-tetra- chloroethane
K083	Aniline, diphenylamine, nitrobenzene, phenylenediamine
K084	Arsenic
K085	Benzene, dichlorobenzenes, trichlorobenzenes, tetra- chlorobenzene, pentachloro- benzene, hexachlorobenzene, benzyl chloride
K086	Lead, hexavalent chromium
K087	Phenol, naphthalene
K088	Cyanide (complexes)
K090	Chromium
K091	Chromium
K093	Phthalic anhydride, maleic anhydride
K094	Phthalic anhydride
K095	1,1,2-trichloroethane, 1,1,1,2-tetrachloroethane, 1,1,2,2-tetrachloroethane
K096	1,2-dichloroethane, 1,1,1-trichloroethane, 1,1,2-trichloroethane
K097	Chlordane, heptachlor
K098	Toxaphene
K099	2,4-dichlorophenol, 2,4,6-trichlorophenol
K100	Hexavalent chromium, lead, cadmium
K101	Arsenic
K102	Arsenic
Kl03	Aniline, nitrobenzene, phenylenediamine
K104	Aniline, benzene, diphenylamine, nitrobenzene, phenylenediamine
K105	Benzene, monochlorobenzene, dichlorobenzenes, 2,4,6-trichlorophenol
K106	Mercury
K107	1,1-Dimethylhydrazine (UDMH)
K108	1,1-Dimethylhydrazine (UDMH)
K109	1,1-Dimethylhydrazine (UDMH)
K110	1,1-Dimethylhydrazine (UDMH)
K111	2,4-Dinitrotoluene,
K112	2,4-Toluenediamine, o-toluidine, p-toluidine, aniline
K113	2,4-Toluenediamine, o-toluidine, p-toluidine, aniline
K114	2,4-Toluenediamine, o-toluidine, p-toluidine
K115	2,4-Toluenediamine,
K116	Carbon tetrachloride, tetrachloroethylene, chloroform, phosgene
K117	Ethylene dibromide
K118	Ethylene dibromide
K119**	Chlorobenzene, linuron
K120**	Chlorobenzene, bromacil
K121**	Bromacil
K123	Ethylene thiourea
K124	Ethylene thiourea
K125	Ethylene thiourea
K126	Ethylene thiourea
K131	Methyl bromide, dimethylsulfate
K132	Methyl bromide
K136	Ethylene dibromide
K138			1,1-Dimethylhydrazine (UDMH)
K141	Benzene, benz(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, benzo(k)fluoranthene, dibenz(a,h)anthracene, indeno(1,2,3-cd)pyrene
K142	Benzene, benz(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, benzo(k)fluoranthene, dibenz(a,h)anthracene, indeno(1,2,3-cd)pyrene
K143			Benzene, benz(a)anthracene, benzo(b)fluoranthene, benzo(k)fluoranthene
K144	Benzene, benz(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, benzo(k)fluoranthene, dibenz(a,h)anthracene.
K145	Benzene, benz(a)anthracene, benzo(a)pyrene, dibenz(a,h)anthracene, naphthalene
K147	Benzene, benz(a)anthracene, benzo(a)pyrene,benzo(b)fluoranthene, benzo(k)fluoranthene, dibenz(a,h)anthracene, indeno(1,2,3-cd)pyrene
K148	Benz(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, benzo(k)fluoranthene, dibenz(a,h)anthracene, indeno(1,2,3-cd)pyrene
K149	Benzotrichloride, benzyl chloride, chloroform, chloromethane, chlorobenzene, 1,4-dichlorobenzene, hexachlorobenzene, pentachlorobenzene, 1,2,3,5-tetrachlorobenzene, toluene
K150	Carbon tetrachloride, chloroform, chloromethane, 1,4-dichlorobenzene, hexachlorobenzene, pentachlorobenzene, 1,2,4,5-tetrachlorobenzene, 1,1,2,2-tetrachloroethane, tetrachloroethylene, 1,2,4-trichlorobenzene
K151	Benzene, carbon tetrachloride, chloroform, hexachlorobenzene, pentachlorobenzene, toluene, 1,2,4,5-tetrachlorobenzene, tetrachloroethylene

* 55 FR 18507, May 2, 1990, proposed rule
**50 FR 18626, May 1, 1985, Proposed Rule
                                APPENDIX VIII:
                            HAZARDOUS CONSTITUENTS

--------------------------------------------------------------------------------
Common name	Chemical abstracts name

Acenaphthene,5-nitro**
Acetamide, N-(4-(5-nitro-2-furyl)-2-thiazolyl)-**
Acetonitrile	Same
Acetophenone	Ethanone, 1-phenyl-
2-Acetylaminofluorene	Acetamide, N-9H-fluoren-2-yl-
Acetyl chloride	Same
1-Acetyl-2-thiourea	Acetamide, N-(aminothioxomethyl)-
Acrolein	2-Propenal
Acrylamide 	2-Propenamide
Acrylonitrile	2-Propenenitrile
Actinomycin D**
Aflatoxins	Same
Aldicarb	Propanal, 2-methyl-2-(methylthio)-,0-[(methylamino)carbonyl]oxime
Aldrin	1,4,5,8-Dimethanona
	phthalene, 1,2,3,4,10,10-10-hexachloro-1,4,4a,5,
	8,8a-hexahydro-(1alpha,4alpha,4abeta,
	5alpha,8alpha,8abeta)-,
Allyl alcohol	2-Propen-1-ol
Allyl-chloride	1-Propane, 3-Chloro
Aluminum phosphide	Same
3-Amino-9-ethyl carbazole**
p-aminoazobenzene	4-(phenylazo) benzenamine-**)
o-Aminoazotoluene	o-Toluidine, 4-(o-tolylazo)-**
4-Aminobiphenyl	[1,1'-Biphenyl]-4 amine
5-(Aminomethyl)-3-isoxazolol	3(2H)-Isoxazolone, 5-(aminomethyl)-
4-Aminopyridine	4-Pyridinamine
Amitrole	1H-1,2,4-Triazol-
	3-amine
Ammonium vanadate	Vanadic acid, ammonium salt
Anilazine	S-Triazine, 2,4-dichloro-6
	(o-chloroanilino)-**
Aniline	Benzenamine
Aniline, 4-4'-methylenebis-(N-N-dimethyl-)-**
Aniline, 4-4'-methylenebis-(2-methyl-)-**
Aniline, 4,4'-thiodi-
Aniline, 2,4,5-trimethyl-**
0-Anisidine**
0-Anisidine hydrochloride**
0-Anisidine, 5-methyl-**
0-Anisidine, 5-nitro-**
Anthraquinone, 2-amino-**
Anthraquinone, 1-amino-2-methyl-**
Anthraquinone, 2-methyl-1-nitro-**
Antimony	Same
Antimony compounds,N.O.S.1
Aramite	Sulfurous acid, 2-chloroethyl-2- [4-(1,1-dimethylethyl)-phenoxy]-1-methylethyl ester
Arsenic	Same
Arsenic compounds, N.O.S.1
Arsenic acid	Arsenic acid H3AsO4
Arsenic pentoxide	Arsenic oxide As2O5
Arsenic trioxide	Arsenic oxide As2O3
Asbestos**
Auramine	Benzenamine, 4,4'-carbonimidoylbis [N,N-dimethyl]-, monohydrochloride
Azinphos ethyl	Phosphorodithioic acid, O,O-diethyl ester, S-ester with 3-(mercaptomethyl) -1,2,3-benzotriazin-4(3H)-one**
Azinphos methyl	Phosphorodithioic acid, O,O-dimethyl ester, S-ester with 3-(mercaptomethyl)-1,2,3-benzotriazine-4(3H)-one**
Azaserine	L-Serine, diazoacetate (ester)
Barban	Carbanilic acid, m-chloro, 4-chloro-2-butynyl
	ester*
Barbituric acid, 5-ethyl-5 phenyl-**	2,4,6 (1H,3H, 5H) - pyrimidinetrione
Barium	Same
Barium compounds, N.O.S.1
Barium cyanide	Same
Bendiocarb	Carbamic acid, methyl-2,3-(dimethyl- methylenediox)phenyl ester
Benz[c]acridine	Same
Benz[a]anthracene	Same
Benzal chloride	Benzene, (dichloromethyl)-
Benzene	Same
Benzenamine hydrochloride**
Benzenearsonic acid	Arsonic acid, phenyl-
Benzidine	[1,1'-Biphenyl]-4,4'-diamine
Benzidine sulfate**
Benzimidazolecarbamic acid, 1-(butyl-carbamoyl)-methyl ester
Benzo[b]fluoranthene	Benz[e] [acephenanthrylene
Benzo[j]fluoranthene	Same
Benzo(k)fluoranthene	Same
Benzo[a]pyrene	Same
p-Benzoquinone	2,5-Cyclohexadiene-1,4-dione
Benzotrichloride	Benzene, (trichloromethyl)-
Benzyl chloride	Benzene, (chloromethyl)-
Beryllium powder	Same
Beryllium compounds,N.O.S.1
Biphenyl, 4-nitro-**
Bromoacetone	2-Propanone, 1-bromo-
Bromacil 	Uracil, 6-methyl-, 5-bromo-3-sec-butyl
Bromoform	Methane, tribromo-
4-Bromophenyl phenyl ether	Benzene, 1-bromo-4-phenoxy-
Bromoxynil	Benzonitrile, 3,5-dibromo-4-hydroxy*
Brucine	Strychnidin-10-one, 2,3-dimethoxy-
1,3'-Butadiene, 2-chloro-**
1-Butanol, 4-(butylnitrosamino)-**
                                       Butyl benzyl phthalate	1,2-Benzene dicarboxylic acid, butyl phenylmethyl ester
Cacodylic acid	Arsinic acid, dimethyl-
Cadmium	Same
Cadmium compounds, N.O.S.1
Calcium chromate	Chromic acid H2CrO4,calcium salt
Calcium cyanide	Calcium cyanide Ca(CN)2
Captafol	4-Cyclohexene-1,2-dicarboximide, N-(1,1,2,2-tetrachloroethyl)thio-**
Captan	4-Cyclohexene-1,2-dicarboximide, N-(trichloromethyl)thio-
Carbaryl	Carbamic acid, methyl-, 1-naphthyl ester*
Carbofuran	Carbamic acid, methyl, 2,3-dihydro-
	2,2-dimethyl-7-benzofuranyl ester**
Carbon disulfide	Same
Carbon oxyfluoride	Carbonic difluoride
Carbon tetrachloride	Methane, tetrachloro
Carbophenothion	Phosphorodithioic acid S-(((p-chlorophenyl)thio)methyl) O,O-diethyl ester**
Chloral	Acetaldehyde, trichloro-
Chlorambucil	Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]-
Chlordane	4,7-Methano-1 	H-indene, 1,2,4,5,6,7,8,8-octachloro-2,3,3a, 4,7,7a-hexahydro-.
Chlordane(alpha and gamma isomers)
Chlorfenvinphos 	Phosphoric acid, 2-chloro-1-(2,4-dichlorophenyl)vinyl diethyl ester**
Chlorinated benzenes, N.O.S.1
Chlorinated ethane, N.O.S.1
Chlorinated fluorocarbons, N.O.S.1
Chlorinated napthalene, N.O.S.1
Chlorinated phenol, N.O.S.1
Chlorine**
Chlornaphazin	2-Naphthalenamine, N,N'-bis(2-chloroethyl)-
Chloroacetaldehyde	Acetaldehyde, chloro-
Chloroalkyl ethers, N.O.S.1
p-Chloroaniline	Benzenamine, (4-chloro-
Chlorobenzene	Benzene, chloro-
Chlorobenzilate	Benzeneacetic acid, 4-chloro-alpha-(4-chloro-phenyl)-alpha-hydroxy-, ethyl ester
p-Chloro-m-cresol	Phenol, 4-chloro-3-methyl-
Chloroethanol	Ethanol, 2-chloro-**
2-Chloroethyl vinyl ether	Ethene, (2-chloroethoxy)-
Chloroform	Methane, trichloro-
Chloromethyl methyl ether	Methane, chloromethoxy-
beta-Chloronaphthalene	Naphthalene, 2-chloro-
o-Chlorophenol	Phenol,2-chloro-
1-(o-Chlorophenyl)thiourea	Thiourea, (2-chlorophenyl)-
Chloroprene	1,3-Butadiene, 2-chloro-
3-Chloropropionitrile	Propanenitrile, 3-chloro-
Chlorpyrifos	Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) ester**
Chromium	Same
Chromium compounds, N.O.S.1
Chrysene	Same
Citrus red No. 2	2-Naphthalenol, 1-(2,5-dimethoxyphenyl)azo]-
Clonitralid	Salicylanilide, 2',5-dichloro-4'-nitro-, compound with 2-aminoethanol (l:l)**
Coal tar creosote	Same
Cobalt, when in the form of particles
 100 microns or less**
Cobalt (II) chloride**
Copper cyanide	Copper cyanide CuCN
Coumaphos 	Phosphorothioic acid, 0-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl)0,0-diethyl ester (Coumarin, 3-chloro-7-hydroxy-4-methyl,-0-ester with 0,0-diethyl phosphorothioate)
Coumarin, 	3-chloro-7-hydroxy-4-methyl-0-ester with 0,0-diethylphosphorothioate**
Creosote	Same
Cresol (Cresylic acid)	Phenol, methyl-
Crotoxyphos 	2-Butenoic acid, 3-((dimethoxyphos-phinyl)oxy)-, 1-phenylethyl ester (Crotonic acid, 3-hydroxy-, alpha-methylbenzyl ester, dimethyl phosphate (E)-)
Crotonaldehyde	2-Butenal
Cyanides (soluble salts and complexes
 N.O.S1
Cyanogen	Ethanedinitrile
Cyanogen bromide	Cyanogen bromide (CN)Br
Cyanogen chloride	Cyanogen chloride (CN)Cl
Cycasin	beta-D-Glucopyranoside, (methyl-ONN-azoxy)methyl
2-Cyclohexyl-4,6-dinitrophenol	Phenol, 2-cyclohexyl-4,6-dinitro-
Cyclophosphamide	2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-,2-oxide
2,4-D	Acetic acid, (2,4-dichlorophenoxy)-
2,4-D, salts, esters
Daunomycin	5,12-Naphtha cenedione, 8-acetyl-10[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methyoxy-, (8S-cis)-
DDD	Benzene, 1,1'-(2,2-dichloroethylidene)
	bis(4-chloro-,
DDE	Benzene, 1,1'-(dichloroethenylidene)
	bis(4-chloro-
DDT	Benzene, 1,1'-(2,2,2-trichloro-ethylidene)bis(4-chloro-
Demeton	Phosphorothioic acid, O,O-diethyl
	0-(2-(ethylthio)ethyl) ester, mixed with
	 O,O-diethyl S-(2-(ethylthio)ethyl) ester (7:3)**
Diallate	Carbamothioic acid, bis(1-methyl-ethyl)-, S-(2,3-dichloro-2-propenyl) ester
Diazinon	Phosphorothioic acid, O,O-diethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl) ester**
Dibenz[a,h]acridine	Same
Dibenz[a,j]acridine	Same
Dibenz[a,h]anthracene	Same
7H-Dibenzo[c,g]carbazole	Same
Dibenzo[a,e]pyrene	Naphtho[1,2,3,4-def] chrysene
Dibenzo[a,h]pyrene	Dibenzo[b,def] chrysene
Dibenzo[a,i]pyrene	Benzo[rst] pentaphene
1,2-Dibromo-3-chloropropane	Propane, 1,2-dibromo-3-chloro-
Dibutyl phthalate	1,2-Benzenedi carboxylic acid, dibutyl ester
Dichlone 	1,4-Naphthalene dione, 2,3- dichloro-**
o-Dichlorobenzene	Benzene, 1,2-dichloro-
m-Dichlorobenzene	Benzene, 1,3,-dichloro-
p-Dichlorobenzene	Benzene, 1,4-dichloro-
Dichlorobenzene, N.O.S.1	Benzene, dichloro-
3,3'-Dichlorobenzidine	[1,1'-Biphenyl] -4,4'-diamine, 3,3'-dichloro-
1,4-Dichloro-2-butene	2-Butene,1,4-dichloro-
Dichlorodifluoromethane	Methane, dichlorodifluoro-
Dichloroethylene, N.O.S.1	Dichloroethylene
1,1-Dichloroethylene	Ethene, 1,1-dichloro-
1,2-Dichloroethylene	Ethene, 1,2-dichloro-, (E)-
Dichloroethyl ether	Ethane, 1,1'oxybis[2-chloro-
Dichloroisopropyl ether	Propane, 2,2'-oxybis[2-chloro-
Dichloromethoxy ethane	Ethane, 1,1'-[methylenebis(oxy)] bis[2-chloro-
Dichloromethyl ether	Methane, oxybis[chloro-
2,4-Dichlorophenol	Phenol, 2,4-dichloro-
2,6-Dichlorophenol	Phenol, 2,6-dichloro-
Dichlorophenylarsine	Arsonous dichloride, phenyl-
Dichloropropane, N.O.S.1	Propane, dichloro-
Dichloropropanol, N.O.S.1	Propanol, dichloro-
Dichloropropene, N.O.S.1	Propene, dichloro-
1,3-Dichloropropene	Propene, 1,3-dichloro-
Dichlorvos	Phosphoric acid, 2,2-dichlorovinyl 	dimethyl ester**
                                       Dieldrin	2,7:3,6-Dimethanona phth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-,(1aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7beta,7aalpha)-
1,2:3,4-Diepoxybutane	2,2'-Bioxirane
Diethylarsine	Arsine, diethyl-
1,4-Diethyleneoxide	1,4-Dioxane
Diethylhexyl phthalate	1,2-Benzenedi-carboxylic acid, bis(2-ethylhexyl) ester
N,N'-Diethylhydrazine	Hydrazine, 1,2-diethyl-
O,O-Diethyl S-methyl dithiophosphate	Phosphorodithioic acid, O,O-diethyl S-methyl
	 ester
Diethyl-p-nitrophenyl phosphate	Phosphoric acid, diethyl 4-nitro-phenyl ester
Diethyl phthalate	1,2-Benzenedi-carboxylic acid, diethyl ester
O,O-Diethyl O-pyrazinyl phosphorothioate	Phosphorothioc acid, O,O-diethyl O-	pyrazinyl ester
Diethylstilbesterol	Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl) bis-(E)
Diethyl sulfate 	Sulfuric acid, diethyl ester**
Dihydrosafrole	1,3-Benzodioxole, 5-propyl-
Diisopropylfluorophosphate (DFP)	Phosphorofluoridic acid, bis(1-methylethyl) ester
Dimethoate	Phosphorodithioic acid, O,O-dimethyl S[2-(methylamino)-2-oxoethyl] ester
3,3'-Dimethoxybenzidine	[1,1'-Biphenyl]-4,-4'-diamine, 3,3'-	dimethoxy-
p-Dimethylaminoazobenzene	Benzenamine, N,N-dimethyl-4-(phenylazo)-
7,12-Dimethylbenz[a]anthracene	Benz[a]anthracene,-7,12-dimethyl-
3,3'-Dimethylbenzidine	[1,1'-Biphenyl]-4,-4'-diamine,3,3'-dimethyl-
Dimethylcarbamoyl chloride	Carbamic chloride, dimethyl-
1,1-Dimethylhydrazine	Hydrazine, 1,1-dimethyl-
1,2-Dimethylhydrazine	Hydrazine, 1,2-dimethyl-
alpha,alpha-Dimethylphenethylamine	Benzeneethanamine, alpha, alpha-dimethyl-
2,4-Dimethylphenol	Phenol, 2,4-dimethyl-
Dimethyl phthalate	1,2-Benzenedi-carboxylic acid, dimethyl ester
Dimethyl sulfate	Sulfuric acid, dimethyl ester
Dinitrobenzene, N.O.S.1	Benzene, dinitro-
4,6-Dinitro-o-cresol	Phenol, 2-methyl-4,6-dinitro-
4,6-Dinitro-o-cresol salts
2,4-Dinitrophenol	Phenol, 2,4-dinitro-
2,4-Dinitoluene	Benzene, 1-methyl-2,4-dinitro-
2,6-Dinitrotoluene	Benzene, 2-methyl-1,3-dinitro-
Dinocap	Crotonic acid, 2-(1-methylheptyl)-4,6-dinitrophenyl ester
Dinoseb	Phenol, 2-(1-methylpropyl)-4,6-dinitro-
Di-n-octyl phthalate	1,2-Benzenedi-carboxylic acid, dioctyl ester
Diphenylamine	Benzenamine, N-phenyl-
1,2-Diphenylhydrazine	Hydrazine, 1,2-diphenyl-
Di-n-propylnitrosamine	1-Propanamine, N-nitroso-N-propyl
Dioxathion	Phosphorodithioic acid, S,S'-p-dioxane-2,3-
	diyl O,O,O',O'-tetraethyl ester**
Disulfoton	Phosphorodithioic acid, O,O-diethyl S-[2-(ethylthio)ethyl] ester
Dithiobiuret	Thioimidodicarbonic diamide [(H2N)C(S)]2NH
Endosulfan	6,9-Methano-2,4,-3-benzodioxa-thiepin,6,7,8,9,10,10-hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide
Endothall	7-Oxabicyclo-[2.2.1]heptane-2,-3-dicarboxylic acid
                                       Endrin	2,7:3,6-Dimetha-nonaphth[2,3-b]-oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a,octa-hydro-(1aalpha,2beta,2abeta,3alpha,6alpha,6abeta,7beta,7aalpha)-
Endrin metabolites
Epichlorohydrin	Oxirane, (chloromethyl)-
Epinephrine	1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-,(R)-
EPN	Phosphonothioic acid, phenyl-,O-ethyl O-(p-nitrophenyl) ester**
Ether, 2,4-dichlorophenyl p-nitrophenyl**
Ethion	Phosphorodithioic acid, S,S'-methylene
	 O,O,O',O'-tetraethyl ester**
Ethyl carbamate (urethane)	Carbamic acid, ethyl ester
Ethyl cyanide	Propanenitrile
Ethylenebisdithiocarbamic acid	Carbamodithioic acid, 1,2-ethanediylbis-
Ethylenebisdithiocarbamic acid, salts and esters.
Ethylene dibromide	Ethane, 1,2-dibromo-
Ethylene dichloride	Ethane, 1,2-dichloro-
Ethylene glycol monoethyl ether	Ethanol, 2-ethoxy-
Ethyleneimine	Aziridine
Ethylene oxide	Oxirane
Ethylenethiourea	2-Imidazolid-	inethione
Ethylidene dichloride	Ethane, 1,1-dichloro-
Ethyl methacrylate	2-Propenoic acid, 2-methyl-,ethyl ester
Ethyl methanesulfonate	Methanesulfonic acid, ethyl ester
Famphur	Phosphorothioic acid, O-[4-[(dimethylamino)
	sulfonyl]phenyl]O,O-dimethyl ester
Fensulfothion	Phosphorothioic acid, O,O-diethyl O-(p-(methylsulfinyl)phenyl) ester**
Fenthion	Phosphorothioic acid, O,O-dimethyl-, O-(4-methylthio)-m-tolyl) ester**
Fluchloralin	p-Toluidine, N-(2-chloroethyl)-2,6-dinitro-N-propyl-alpha,alpha,alpha-trifluoro-**
Fluoranthene	Same
Fluorine	Same
Fluoroacetamide	Acetamide, 2-fluoro-
Fluoroacetic acid, sodium salt	Acetic acid, fluoro-, sodium salt
Formaldehyde	Same
Formic acid	Same
Glutarimide, 3-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-**
Glycidylaldehyde	Oxirane carboxyaldehyde
Halomethanes, N.O.S.1
Heptachlor	4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a- tetrahydro-
Heptachlor epoxide	2,5-Methano-2H-indeno[1,2-b]oxirene 2,3,4,5,6,7,7-heptachloro-1a,1b,5,5a,6,6a-hexahydro-, 1aalpha,1bbeta,2alpha,5alpha,5abeta, 6beta,6aalpha)-
Heptachlor epoxide (alpha,beta,and gamma isomers).
Hexachlorobenzene	Benzene, hexachloro-
Hexachlorobutadiene	1,3-Butadiene, 1,1,2,3,4,4-hexachloro-
Hexachlorocyclopentadiene	1,3-Cyclo pentadiene, 1,2,3,4,5,5-hexachloro-
Hexachlorodibenzo-p-dioxins
Hexachlorodibenzofurans
Hexachloroethane	Ethane, hexachloro-
Hexachlorophene	Phenol, 2,2'-methylenebis[3,4,6-trichloro-
Hexachloropropene	1-Propene,1,1,2,3,3,3-hexachloro-
Hexaethyl tetraphosphate	Tetraphosphoric acid, hexaethyl ester
Hexamethyl phosphoramide	Phosphoric triamide, hexamethyl-**
Hydantoin, 5,5-diphenyl-**	2,4-Imidazo lidinedione, 5,5-diphenyl-
Hydantoin, 5,5-diphenyl-, monosodium salt**
Hydrazine	Same
Hydrogen cyanide	Hydrocyanic acid
Hydrogen fluoride	Hydrofluoric acid
Hydrogen sulfide	Hydrogen sulfide H2S
Hydroquinone**
Hydroxylamine, N-nitroso-N-phenyl-, ammonium salt**
Hypochlorous acid, calcium salt**
Hypochlorous acid, sodium salt**
Indeno[1,2,3-cd]pyrene	Same
Iron dextran	Same
Isobutyl alcohol	1-Propanol, 2-methyl-
Isodrin	1,4,5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a,hexahydro-,(1alpha,4alpha,4abeta,5beta,8beta,8abeta)-
Isonicotinic acid hydrazide**
Isosafrole	1,3-Benzo-dioxole,5-(1-propenyl)-
Kepone	1,3,4-Metheno-2H-cyclobuta[cd] pentalen-2-one, 1,1a,3,3a,4,5,5,5a,5b,6-decachlorooctahydro-
Ketene**
Lasiocarpine	2-Butenoic acid, 2-methyl-,7-[[2,3-dihydroxy-2-(1-methoxyethyl)-3-methyl-1-oxobutoxy]methyl]2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yl ester,[1S-[1alpha(Z),7(2S*,3R*),7aalphal]]-
Lead	Same
Lead compounds, N.O.S.1
Lead acetate	Acetic acid, lead(2+)salt
Lead phosphate	Phosphoric acid, lead(2+)salt(2:3)
Lead subacetate	Lead,bis-(acetato-O)tetrahydroxytri-
Leptophos	Phosphonothioic acid, phenyl-,0-(4-bromo-2,5-dichlorophenyl) O-methyl ester**
Lindane	Cyclohexane, 1,2,3,4,5,6-hexachloro-, (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-
                                       Linuron 	(Urea, N'-(3,4-dichlorophenyl)-N-methoxy-N-methyl-*
Lithium**
Malachite green	Ammonium, (4-(p-(dimethylamino)-alpha-phenylbenzylidene)-2,5-cyclohexadien-1-ylidene)-dimethyl-, chloride**
Malathion	Succinic acid, mercapto-, diethyl ester, S-ester with O,O-dimethyl phosphorodithioate**
Maleic anhydride	2,5-Furandione
Maleic hydrazide	3,6-Pyri	dazinedione, 1,2-dihydro-
Malononitrile	Propanedinitrile
Melphalan	L-Phenylalanine, 4-[bis(2-chloro-ethyl)aminol]-
Mercury	Same
Mercury compounds, N.O.S.1
Mercury fulminate	Fulminic acid, mercury(2+)salt
Mestranol	17 alpha 19 Norpregna 1,3,5(10) trien 20 yn 17 ol, 3 methoxy **
Methacrylonitrile	2-Propenenitrile, 2-methyl-
Methapyrilene	1,2-Ethanediamine, N,N-dimethyl-N'-2-pyridinyl-N'-(2-thienylmethyl-
Methomyl	Ethanimidothioic acid, N-[[(methylamino)carbonyl]oxy]-,methyl ester
Methoxychlor	Benzene, 1,1'-(2,2,2-trichloro-ethylidene)bis[4-methoxy-
Methyl bromide	Methane, bromo-
Methyl chloride	Methane, chloro-
Methyl chlorocarbonate	Carbonochloridic acid, methyl ester
Methyl chloroform	Ethane, 1,1,1-trichloro-
3-Methylcholanthrene	Benz[j]acean-thrylene, 1,2-dihydro-3-methyl-
4,4'-Methylenebis(2-chloroaniline)	Benzenamine, 4,4'-methylenebis[2-chloro-
Methylene bromide 	Methane, dibromo-
Methylene chloride 	Methane, dichloro-
Methyl ethyl ketone (MEK) 	2-Butanone
Methyl ethyl ketone peroxide	2-Butanone, peroxide
Methyl hydrazine 	Hydrazine, methyl-
Methyl iodide 	Methane, iodo-
Methyl isocyanate 	Methane, isocyanato
2-Methyllactonitrile	Propanenitrile, 2-hydroxy-2-methyl-
Methyl methacrylate	2-Propenoic acid, 2-methyl-,methyl ester
Methyl methanesulfonate	Methanesulfonic acid, methyl ester
Methyl parathion	Phosphorothioic acid, O-O-dimethyl
	 O-(4-nitrophenyl)ester
Methylthiouracil	4(1H)-Pyrimidinone,2,3-dihydro-6-methyl-2-thioxo-
Mevinphos	2-Butenoic acid, 3-((dimethoxyphos-phinyl)oxy)-, methyl ester (Crotonic acid, 3-hydroxy-, methyl ester, dimethyl phosphate, (E)-)
Mexacarbate	Carbamic acid, methyl,4-dimethylamino-3,5-xylyl ester**
Mirex	1,3-Metheno-1H-cyclobuta-[cd]pentalene, 1,1a,2,2,3,3a,4,5,5,5a,5b,6-dodecachlorooctahydro**
Mitomycin C	Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8[[amino-carbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-,[1aS-(1aalpha,8beta,8aalpha,8balpha)]-
MNNG	Guanidine, N-methyl-N'-nitro-N-nitroso-
Monocrotophos	Phosphoric acid, dimethyl ester, ester with (E)-3-hydroxy-N-methylcrotonamide
Mustard Gas	Ethane, 1,1'-thiobis[2-chloro-
Naled	Phosphoric acid, 1,2-dibromo-2,2-dichloroethyl-dimethyl ester**
Naphthalene	Same
1,5-Naphthalenediamine**
1,4-Naphthoquinone	1,4-Naphthalene-dione
alpha-Naphthylamine	1-Naphthalenamine
beta-Naphthylamine	2-Naphthalenamine
alpha-Naphthylthiourea	Thiourea, 1-naphthalenyl-
Nickel	Same
Nickel compounds, N.O.S.1
Nickel carbonyl	Nickel carbonyl Ni(CO)4 (T-4)-
Nickel cyanide	Nickel cyanide (Ni(CN)2
Nicotine	Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-
Nicotine salts
Nithiazide	Urea, 1-ethyl-3(5-nitro-2-thiazolyl)**
Nitric oxide	Nitrogen oxide NO
Nitridazole	2-Imidazolidinone, 1-(5-nitro-2-thiazolyl-**
p-Nitroaniline	Benzenamine, 4-nitro-
Nitrobenzene	Benzene, nitro-
Nitrogen dioxide	Nitrogen oxide NO2
Nitrogen mustard	Ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl-
Nitrogen mustard, hydrochloride salt
Nitrogen mustard N-oxide	Ethanamine, 2-chloro-N-(2-chloro-ethyl)-N-methyl- ,N-oxide
Nitrogen mustard, N-oxide, hydrochloride salt
Nitroglycerin	1,2,3-Propanetriol, trinitrate
p-Nitrophenol	Phenol, 4-nitro-
2-Nitropropane	Propane, 2-nitro-
Nitrosamines, N.O.S.1
N-Nitrosodi-n-butylamine	1-Butanamine, N-butyl-N-nitroso-
N-Nitrosodiethanolamine	Ethanol,2,2'-(Nitrosoimino)bis-
N-Nitrosodiethylamine	Ethanamine, N-ethyl-N-Nitroso-
N-Nitrosodimethylamine	Methanamine, N-methyl-N-nitroso-
p-Nitrosodiphenylamine	Diphenyl-amine, 4-nitroso-**
N-Nitroso-N-ethylurea	Urea, N-ethyl-N-nitroso-
N-Nitrosomethylethylamine	Ethanamine, N-methyl-N-nitroso-
N-Nitroso-N-methylurea	Urea, N-methyl-N-nitroso-
N-Nitroso-N-methylurethane	Carbamic acid, methylnitroso-,ethyl ester
N-Nitrosomethylvinylamine	Vinylamine, N-methyl-N-nitroso-
N-Nitrosomorpholine	Morpholine, 4-nitroso-
N-Nitrosonornicotine	Pyridine, 3-(1-nitroso-2-py-rrolidinyl)-, (S)-
N-Nitrosopiperidine	Piperidine, 1-nitroso-
N-Nitrosopyrrolidine	Pyrrolidine, 1-nitroso-
N-Nitrososarcosine	Glycine, N-methyl-N-nitroso-
5-Nitro-o-toluidine	Benzenamine, 2-methyl-5-nitro-
Octamethylpyrophosphoramide	Diphosphoramide, octamethyl-
Osmium tetroxide	Osmium oxide OsO4 (T-4)-
2-Oxetanone**
Oxydemeton-Methyl	Phosphorothioic acid, S-(2-(ethyl-sulfinyl)ethyl) O,O-dimethyl ester**
4,4'-Oxydianiline
Paraldehyde	1,3,5,-Trioxane, 2,4,6-tri-methyl-
Paraquat	4,4'-Bipyridinium, 1,1'-dimethyl-,dichloride**
Parathion	Phosphorothioic acid, O,O-diethyl O-(4-nitrophenyl)ester
Pentachlorobenzene	Benzene, pentachloro-
Pentachlorodibenzo-p-dioxins
Pentachlorodibenzofurans
Pentachloroethane	Ethane, pentachloro-
Pentachloronitrobenzene (PCNB)	Benzene, pentachloronitro-
Pentachlorophenol	Phenol, pentachloro-
Peroxyacetic acid**
Phenacetin	Acetamide, N-(4-ethoxyphenyl)-
Phenestrine 	Acetic acid,(4-(bis(2-chloroethyl)amino)
	phenyl),cholesteryl ester**
Phenol	Same
m-Phenylenediamine, 4-chloro-**
o-Phenylenediamine, 4-chloro-**
Phenylenediamine	Benzenediamine
Phenylmercury acetate	Mercury, (acetato-O)phenyl-
Phenylthiourea	Thiourea, phenyl-
Phorate	Phosphorodithioic acid,O,O-diethylS-[(ethylthio)methyl] ester
Phosacetim 	Phosphoramidothioic acid, acetimidoyl-0,0-bis(p-chlorophenyl ester*
Phosgene	Carbonic dichloride
Phosmet	Phosphorodithioic acid, O,O-dimethyl ester, S-ester with N-(mercaptomethyl)phthalimide**
Phosphamidon	Phosphoric acid, dimethyl ester, ester with 2-chloro-N,N-diethyl-3-hydroxy-crotonamide**
Phosphine	Same
Phthalic acid esters, N.O.S.1
Phthalic anhydride	1,3-Isobenzofurandione
2-Picoline	Pyridine, 2-methyl-
Piperonyl sulfoxide	Benzene, 1,2-(methylenedioxy)-	4-(2-octylsulfinyl) propyl**
Polybrominated biphenyls**
Polychlorinated biphenyls, N.O.S.1
Potassium cyanide	Potassium cyanide K(CN)
Potassium pentachlorophenate	Pentachlorophenol, potassium salt
Potassium silver cyanide	Argentate(1-),bis(cyano-C)-, potassium
Pronamide	Benzamide, 3,5-dichloro-N-(1,1-dimethyl-2- propynyl)-
1,3-Propane sulfone	1,2-Oxathiolane, 2,2-dioxide
Propargyl alcohol	2-Propyn-1-ol
Propene, 3-chloro-**
Propionitrile, 2-hydroxy-**
n-Propylamine	1-Propanamine
Propylthiouracil	Uracil, 6-propyl-2-thio**
Propylene dichloride	Propane, 1,2-dichloro-
1,2-Propylenimine	Azinidine, 2-methyl-
Propylthiouracil	4(1H)-Pyrimidinone,
	2,3-dihydro-6-propyl-2-thioxo-
Pyridine	Same
Pyridine, 3-chloromethyl-, hydrochloride**	Pyridine,2,6-diamino-3-(phenylazo)-, monohydrochloride**
Monocrotaline	(2,3,4-gh)Pyrrolizine-2,6(3H)-dione, (4,5,8,10,12,13,13a,13b-octahydro-4,5-dihy-droxy-3,4,5-trimethyl-2H-(1,6)dioxacycloundecino-**
Reserpine	Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-methylester, (3beta,16beta,17alpha,18beta,20alpha)-
Resorcinol	1,3-Benzenediol
Rotenone	(1)Benzopyrano (3,4-b)furo(2,3-h)(1)benzopyran-6(6aH)-one, 1,2,12,12a-tetrahydro-2-alpha-isopropenyl-8,9-dimethoxy-**
Saccharin	1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide
Saccharin salts
Safrole	1,3-Benzodioxole, 5-(2-propenyl)-
Selenium	Same
Selenium compounds, N.O.S.1
Selenium dioxide	Selenious acid
Selenium sulfide	Selenium sulfide SeS2
Selenourea	Same
Semicarbazide**
Silver	Same
Silver compounds, N.O.S.1
Silver cyanide	Silver cyanide Ag(CN)
Silvex (2,4,5-TP)	Propanoic acid, 2-(2,4,5-tri-chlorolorophenoxy)-
Sodium cyanide	Sodium cyanide Na(CN)
Sodium pentachlorophenate	Pentachlorophenol, Sodium salt
Streptozotocin	D-Glucose, 2-deoxy-2-[[(methyl-nitrosoamino)carbonyl]amino]-
Strychnine	Strychnidin-10-one
Strychnine salts
Styrene**
Sulfallate	Carbamic acid, diethyldithio-, 2-chloroallyl ester**
TCDD	Dibenzo[b,e]-[1,4]dioxin, 2,3,7,8-tetrachloro-
Terbufos	Phosphorodithioic acid, O-O-diethyl-S- (((1,1-dimethylethyl)thio)methyl)-ester**
3,3',4,4'-Tetrachloroazobenzene*	bis(3,4-dichloro-phenyl)diazene
3,3',4,4'-Tetrachloroazoxybenzene*	bis (3,4,-dichlorophenyl)diazene-l-oxide
1,2,4,5-Tetrachlorobenzene	Benzene, 1,2,4,5-tetrachloro
Tetrachlorodibenzo-p-dioxins
Tetrachlorodibenzofurans
Tetrachloroethane, N.O.S.1	Ethane, tetrachloro-N.O.S.1
1,1,1,2-Tetrachloroethane	Ethane, 1,1,1,2-tetrachloro
1,1,2,2-Tetrachloroethane	Ethane, 1,1,2,2-tetrachloro
Tetrachloroethylene	Ethene, tetrachloro-
2,3,4,6-Tetrachlorophenol	Phenol, 2,3,4,6-tetrachloro
2,3,4,6-Tetrachlorophenol, potassium salt 	2,3,4,6-Tetrachlorophenol, potassium salt
2,3,4,6-Tetrachlorophenol, sodium salt	2,3,4,6-Tetrachlorophenol, sodium salt
Tetrachlorvinphos	Phosphoric acid, 2-chloro-1-
	(2,4,5-trichlorophenyl)vinyl dimethyl ester**
Tetraethyldithiopyrophosphate	Thiodiphosphoric acid, tetraethyl ester
Tetraethyl lead	Plumbane, tetraethyl-
Tetraethyl pyrophosphate	Diphosphoric acid, tetraethyl ester
Tetranitromethane	Methane, tetranitro-
Thallium	Same
Thallium compounds, N.O.S.1
Thallium (III) oxide	Thallium (III) oxide Tl2O3
Thallium(I) acetate	Acetic acid, thallium(1+)salt
Thallium(I) carbonate	Carbonic acid, dithallium(1+)salt
Thallium(I) chloride	Thallium chloride TlCl
Thallium(I) nitrate	Nitric acid, thallium(1+)salt
Thallium selenite	Selenious acid, dithallium(1+)salt
Thallium(I)sulfate	Sulfuric acid, dithallium(1+)salt
Thioacetamide	Ethanethioamide
Thiofanox	2-Butanone, 3,3-dimethyl-1-(methyl-thio)-,0-[(methylamino)carbonyl] oxime
Thiomethanol	Methanethiol
Thiophenol	Benzenethiol
Thiosemicarbazide	Hydrazine-carbothioamide
Thiourea	Same
Thiram	Thioperoxy-dicarbonic diamide [(H2N)C(S)]2S2, tetramethyl-
Toluene	Benzene, methyl
Toluene, 2,4-diamino**	1,3-Benzenediamine, 4-methyl-
Toluenediamine	Benzenediamine, ar-methyl-
Toluene-2,4-diamine	1,3-Benzenediamine, 4-methyl
Toluene-2,6-diamine	1,3-Benzenediamine, 2-methyl-
Toluene-3,4-diamine	1,2-Benzenediamine, 4-methyl-
Toluene diisocyanate	Benzene, 1,3-diisocyanatomethyl-
o-Toluidine	Benzeneamine, 2-methyl-
o-Toluidine, 5-chloro**
o-Toluidine hydrochloride	Benzenamine, 2-methyl-,hydrochloride
p-Toluidine	Benzenamine, 4-methyl-
Toxaphene	Same
Trichlorfon 	Phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-,dimethyl ester**
Triazene, 3,3'dimethyl-1-(p-chlorophenyl)-**
1,2,4-Trichlorobenzene	Benzene, 1,2,4-trichloro-
1,1,2-Trichloroethane	Ethane, 1,1,2-trichloro-
Trichloroethylene	Ethene, trichloro-
Trichloromethanethiol	Methanethiol, trichloro-
Trichloromonofluoromethane	Methane, trichlorofluoro-
2,4,5-Trichlorophenol	Phenol, 2,4,5-trichloro-
2,4,6-Trichlorophenol	Phenol, 2,4,6-trichloro-
2,4,5-T	Acetic acid, (2,4,5-trichloro- phenoxy)
Trichloropropane, N.O.S.
1,2,3-Trichloropropane	Propane, 1,2,3-trichloro-
Tricresyl phosphate	Phosphoric acid, tri-o-tolyl ester**
O,O,O-Triethyl phosphorothioate	Phosphorothioic acid, O,O,O-triethyl ester
Trifluralin	p-Toluidine, alpha,alpha,alpha-trifluor-2,6-dinitro-N,N-dipropyl**
Trimethyl phosphate	Phosphoric acid, trimethyl ester**
1,3,5-Trinitrobenzene	Benzene, 1,3,5-trinitro-
Tris(1-aziridinyl)phosphine sulfide	Aziridine, 1,1',1"-phosphinothioy-lidynetris-
Tris(2,3-dibromopropyl) phosphate	1-Propanol, 2,3-dibromo-, phosphate(3:1)
Trypan blue	2,7-Naphthal-enedisulfonic acid, 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]-bis[5-amino-4-hydroxy-, tetrasodium salt
Uracil mustard	2,4-(1H,3H)-Pyrimidinedione, 5-[bis-(2-chloroethyl)amino]-
Vanadium pentoxide 	Vanadium oxide, V2O5
Vinyl chloride	Ethene, chloro-
Warfarin	2H-1-Benzopyran-2-one, 4-hydroxy-3- (3-oxo-1-phenylbutyl)-, when present at concentrations less than 0.3%
Warfarin	2H-1-Benzopyran- 2-one, 4-hydroxy-3- (3-oxo-1-phenylbutyl)-, when present at concentrations greater than 0.3%
Warfarin salts, when present at
 concentrations less than 0.3%
Warfarin salts, when present at
 concentrations greater than 0.3%
Zinc cyanide	Zinc cyanide Zn(CN)2
Zinc phosphide	Zinc phosphide Zn3P2, when present at concentrations greater than 10%.
Zinc phosphide	Zinc phosphide Zn3P2, when present at concentrations of 10% or less.
Ziram	Zinc, bis(dimethyldithiocarbamato)-**

1The abbreviation N.O.S. (not otherwise specified) signifies those members of the general class not specifically listed by name in this appendix.

*50 FR 18626, May 1, 1985, Proposed Rule

**49 FR 49793, December 21, 1984, Proposed Rule

                             APPENDIX IX: Reserved

                             APPENDIX X: Reserved

                        APPENDIX XI: PAINT FILTER TEST

"Test Methods for Evaluating Solid Waste, Physical/Chemical Methods," EPA Publication SW-846 [Third Edition]. See Appendix III for instructions on how to obtain copies of this publication.
--------------------------------------------------------------------------------

                  STATUTORY AUTHORITY:	38 M.R.S. §1301, et seq.
                  EFFECTIVE DATE:	July 1, 1980
                  Amended:	March 23, 1983
                  Amended:	June 20, 1983
                  Amended:	February 10, 1985
                  Amended:	November 30, 1986
                  Amended:	March 16, 1994
                                             EFFECTIVE DATE
                                             (ELECTRONIC CONVERSION):	May 4, 1996
                  Amended:	January 23, 2001
                  MINOR CORRECTIONS:	March 5, 2001
                  Amended:	November 3, 2002
                  Amended:	July 20, 2004 - filing 2004-272
                  Amended:	February 8, 2012  -  filing 2012-12
                  Amended:	March 11, 2015  -  filing 2015-030
                  Amended:	June 11, 2018  -  filing 2018-098